NCT03800654

Brief Summary

An emerging scientific model that has been applied to chronic pain is the psychological flexibility (PF) model. PF refers to the ability to behave consistently with one's values even in the face of unwanted thoughts, feelings, and bodily sensations such as pain. Acceptance and Commitment Therapy (ACT) is the best known treatment derived from the PF model and is as effective as the gold standard Cognitive Behavioral Therapy (CBT), but falls short on achieving meaningful changes in functional improvement. Although ACT was designed to impact PF, methods from different treatment approaches are also consistent with the model. An experiential strategy that holds promise for enhancing PF is formal mindfulness meditation, a practice used to train non-judgmental awareness and attention to present-moment experiences, which has never been tested within the PF model. There is compelling theoretical and empirical rationale that the mechanisms underlying formal mindfulness meditation will bolster PF processes and thereby can be applied to facilitate functional improvement. To test this, the principal investigator, has developed a novel 8-week group-based intervention, Mindful Action for Pain (MAP), which integrates formal mindfulness meditation with experiential methods from different evidence-based treatment approaches in accordance with the PF model. MAP is designed such that daily mindfulness meditation practice is used to develop the capacity to more completely utilize strategies to address the key psychosocial barriers (e.g., pain catastrophizing) to optimal functioning. This career development award (CDA-2) project consists of two phases. Phase 1 (years 1 - 2) consists of using qualitative and quantitative methods to iteratively develop and refine MAP over the course of 4 MAP cycles (n = 20). Phase 2 (years 3 - 5) consists of a pilot randomized controlled trial (RCT) (n = 86) of MAP vs. cognitive behavioral therapy (CBT) for chronic pain (CBT-CP) in order to establish feasibility of a future large-scale trial and estimate the preliminary impact of MAP. Functional improvement will be measured by reductions in pain interference (primary clinical outcome). Further, meditation adherence will be assessed to explore dose-response relationships with functional improvement, and objective measures of physical activity (actigraphy) will be captured to explore the psychophysical impact of MAP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 11, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

August 28, 2019

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

January 31, 2025

Completed
Last Updated

February 17, 2026

Status Verified

January 1, 2026

Enrollment Period

4.1 years

First QC Date

January 8, 2019

Results QC Date

November 13, 2024

Last Update Submit

January 28, 2026

Conditions

Keywords

Chronic PainPsychological FlexibilityMindfulness Meditation

Outcome Measures

Primary Outcomes (1)

  • Brief Pain Inventory (BPI) Pain Interference Subscale Change

    The BPI Pain Interference subscale consists of 7-items rated on a 0 - 10 scale that measures the degree to which pain interferes with various aspects of life, including mobility, social activities, and mood. Scores are averaged with a range from 0 to 10. Higher scores indicate higher levels of pain interference (i.e., worse outcome).

    Baseline and week 9

Secondary Outcomes (3)

  • Chronic Pain Acceptance Questionnaire (CPAQ)

    Baseline and week 9

  • Mindfulness Attention Awareness Scale (MAAS)

    Baseline and week 9

  • Pain Catastrophizing Scale (PCS)

    Baseline and week 9

Other Outcomes (2)

  • Meditation Diaries

    Collected daily during the 8-week intervention

  • Actigraphy

    Baseline and week 9

Study Arms (2)

Mindful Action for Pain (MAP) Development

OTHER

In the first arm, MAP will be fully developed.

Behavioral: Mindful Action for Pain

MAP vs. CBT-CP

ACTIVE COMPARATOR

In the second arm, MAP will be compared to CBT-CP to establish feasibility of a larger, future trial.

Behavioral: Mindful Action for PainBehavioral: Cognitive Behavioral Therapy for Chronic Pain

Interventions

MAP integrates formal mindfulness meditation with methods from Acceptance and Commitment Therapy and Dialectical Behavior Therapy.

Also known as: MAP
MAP vs. CBT-CPMindful Action for Pain (MAP) Development

CBT-CP is the current gold standard psychosocial intervention for chronic pain and will be compared to MAP in the second arm of the study.

Also known as: CBT-CP
MAP vs. CBT-CP

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran
  • Diagnosis of a chronic, non-terminal pain condition
  • Pain most days (\> 3 days/week) for at least 6 months
  • Average pain severity and interference with enjoyment of life and/or general activity rated \> 4/10 over the past week

You may not qualify if:

  • Serious or unstable medical or psychiatric illness
  • (e.g., unmanaged psychosis, manic episode, or substance abuse within the past year) or psychosocial instability
  • (e.g., homelessness) that could compromise study participation
  • Active suicidal ideation or history of suicide attempt within past 3 years
  • Current participation in group psychotherapy for pain or any type of individual psychotherapy
  • Changes to professionally delivered pain or mood treatments
  • (e.g., no discontinuation of a treatment; no increasing the dose of medication) one month preceding the baseline assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA San Diego Healthcare System, San Diego, CA

San Diego, California, 92161-0002, United States

Location

MeSH Terms

Conditions

Chronic Pain

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Dr. Matthew Herbert
Organization
VA San Diego Healthcare System

Study Officials

  • Matthew Herbert, PhD

    VA San Diego Healthcare System, San Diego, CA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group Randomized Controlled Trial
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2019

First Posted

January 11, 2019

Study Start

August 28, 2019

Primary Completion

September 29, 2023

Study Completion

March 29, 2024

Last Updated

February 17, 2026

Results First Posted

January 31, 2025

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

A data repository will be created upon completion of the study. Data obtained in this study that has scientific value to other qualified researchers will made available upon request. Interested researches will be able to access de-identified data through a Data Use Agreement.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Indefinitely
Access Criteria
February, 2024

Locations